%0 Journal Article
%T Real-world persistence and benefit¨Crisk profile of fingolimod over 36 months in Germany
%A Bj£¿rn Tackenberg
%A C. Anne-Marie Couto
%A Christian Cornelissen
%A Christoph Lassek
%A Holger Albrecht
%A John A. Findlay
%A Judith Haas
%A Luisa Klotz
%A Michael Lang
%A Stephan Schmidt
%A Tjalf Ziemssen
%A on behalf of the PANGAEA study group
%J Archive of "Neurology£¿ Neuroimmunology & Neuroinflammation".
%D 2019
%R 10.1212/NXI.0000000000000548
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410931/